Mutational concordance analysis provides supportive information for double cancer diagnosis
Open Access
- 19 February 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in BMC Cancer
- Vol. 21 (1), 1-7
- https://doi.org/10.1186/s12885-021-07899-1
Abstract
Mutation analysis using next-generation sequencing highlights the features of tumors with somatic alterations. However, the mutation profile of double cancer remains unclear. Here, we analyzed tumors derived from the same patient using whole exome sequencing (WES) to investigate the coherence of somatic mutations in double cancer. First, the tumor mutational burden (TMB) was investigated using WES of 5521 tumor specimens from a Japanese pan-cancer cohort. The frequencies of mutation concordance were then compared in these cancers. Finally, we calculated the expected value of mutational concordance fitting a Poisson distribution to determine the relationship between double and metastatic cancers. In all, 44, 58, and 121 paired samples were diagnosed as double cancer, multifocal lesions (derived from identical tissues), and metastasis, respectively. Our analysis revealed that common somatic mutations were almost entirely absent in double cancer, whereas primary tumors and metastatic foci harbored several identical alterations. Concordance of the mutation profile in the same patient reflects the tumor origin and development, suggesting the potential for identifying double cancer based on common somatic mutations. Furthermore, according to a Poisson distribution, double cancer could be discriminated based on paired samples from the same patient. The probability of double cancer with more than 10 mutations was ≤1 part-per-billion (ppb, 10− 9). In multifocal lesions, 74% of tumor pairs accumulated ≤10 common mutations, implying a difference in tumor origin within identical tissues. These findings indicate that counting common somatic mutations can indicate the differences in origin between tumors derived from the same patient. Our mutation coherence analysis can thus provide beneficial information for diagnosing double cancer.Keywords
This publication has 16 references indexed in Scilit:
- The evolutionary history of 2,658 cancersNature, 2020
- Japanese version of The Cancer Genome Atlas, JCGA, established using fresh frozen tumors obtained from 5143 cancer patientsCancer Science, 2019
- Pan-cancer whole-genome analyses of metastatic solid tumoursNature, 2019
- Mutational burden and signatures in 4000 Japanese cancers provide insights into tumorigenesis and response to therapyCancer Science, 2019
- Genomic alterations accompanying tumour evolution in colorectal cancer: tracking the differences between primary tumours and synchronous liver metastases by whole-exome sequencingBMC Cancer, 2018
- Mutation Profiling of Key Cancer Genes in Primary Breast Cancers and Their Distant MetastasesCancer Research, 2018
- Integrated analysis of gene expression and copy number identified potential cancer driver genes with amplification-dependent overexpression in 1,454 solid tumorsScientific Reports, 2017
- Optimizing an ion semiconductor sequencing data analysis method to identify somatic mutations in the genomes of cancer cells in clinical tissue samples Biomedical Research, 2016
- Integrated next-generation sequencing analysis of whole exome and 409 cancer-related genes Biomedical Research, 2016
- Next generation sequencing approach for detecting 491 fusion genes from human cancer Biomedical Research, 2016